Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADVR:THE NEW COMPANY...WITH A NEW LIFE...AND A NEW MISSION -- Ignore unavailable to you. Want to Upgrade?

To: Kingfisher who wrote (347)	6/9/1998 12:13:00 PM
From: paper man	Read Replies (1) \| Respond to of 4891

I do see that statement as a direct shot at our FDA. An excellent shot at that! After taking Mr. Allens advice to let these results sink in, I have. I find the results to be positive , recognizing that most patients, regardless of which treatment used; probably die from causes other than VIRAL LOAD. I find that what is most important here is the success in viral load balance with what appears to be an immunomodulator, visavis your own immune system! THIS IS NEW. Thanks for the information Mr. Allen.

To: Kingfisher who wrote (347)	6/9/1998 4:29:00 PM
From: mogo	Read Replies (5) \| Respond to of 4891

<<<<<<<READ ALL!!!!>>>>>>>(not just Kingfisher)..... That (FDA interest) is no reflection on ADVR, Dr. Hirschman, or Reticulose....the U.S. FDA is notoriously (suspiciously!) famous for dragging its feet on any and all anti-cancer and anti-AIDS drugs...that is a well-documented fact. There are a number of drugs used widely throughout the world that have been approved in other countries for years that the U.S. FDA has never gotten around to.....they have been openly criticized for this policy by almost everyone of note. Besides we DO live in a global economy....Americans are often too provincial in outlook...the majority of human beings live OUTSIDE the U.S....they also are the most likely target market for Reticulose. Remember that the number of AIDS and Hep. C cases are growing exponentially in the 3rd world and they may not be able to afford the higher priced competitors for Reticulose, designed for the U.S. market instead....U.S. FDA approval is the toughest standard in the world to meet and they are unfortunately very political about who or what gets attention, yet one need not worry, for even though I understand that all that is going quite well and right on schedule, it is not the most important thing...it is merely going to be the icing on the cake. There is a WHOLE WIDE WORLD out there guys, and that is ADVR's major market...anyone caught just waiting around for U.S. FDA approval is probably going to be left way behind on the next "Rocket-Ride"...."SALES IS SALES" kids, and any news of approval and/or sales overseas will send this stock to the moon (ADVR has LOTS of international contacts and is in no way dependent on your average American "penny-stock" investor). "Don't be lost when the time comes!" Also, there are very, very(VERY!) FEW people who are actually qualified to judge a drug as unusual and complex as Reticulose, much less to talk intelligently about it, and they ALL are probably working on it as we speak with all due speed....if you're not one of them, then keep your damn mouth shut 'cause I'm really getting tired of all this pseudo-intellectual B#!$%t on this thread---you know, plenty of my friends are doctors, but that doesn't mean they know "JACK" about research...just 'cause you went to Med. school and know a few terms means nothing except you probably had rich parents...most doctors I know don't know Heidegger from Hippocrates, much less Reticulose from Ritalin, they just prescribe whatever the big pharm. companies advertise that month and then go golfin'....if they had to take the "BOARDS" again without cramming they'd probably all fail...this myth of "experts" and doctors being some sort of special "priest-class" of citizens is just hogwash....it's pretty much paint-by-numbers for most of them, and they rely on the "placebo-effect" of their patients faith in them just as much as most "faith-healers," and any honest one would tell you that (which is why we never hear about it)....please,therefore, limit the pretentious jargon from now on, no one is impressed....[you know you haven't picked up a serious research journal and read it ALL THE WAY THROUGH since you graduated]...besides, if you do know what your talkin' about go to an appropriate website(with REAL researchers) and jabber to a jury of your peers about it...THIS IS SILICON INVESTOR and we talk about STOCKS in ENGLISH, not Latin. No offence but the price of this stock has nothing whatsoever to do with any of your various unqualified speculations about Reticulose, and comments about any other similar drugs should be discussed on THEIR THREADS. Thank You. <<<<<<<<<<<<<<<GOOOOOOOOOOOOADVR!!!!>>>>>>>>>>>>>>>>>>> (Strictly One Man's Opinion/ Not an offer nor advice to buy or sell).....'Nuff Said!